Hematological parameters and coronary collateral circulation in patients with stable coronary artery disease

Selim Ayhan1, Serkan Ozturk, Alim Erdem

  • 1Abant Izzet Baysal University School of Medicine, Department of Cardiology, Bolu, Turkey.

Insights

Hematological parameters like neutrophil/lymphocyte ratio and mean platelet volume are linked to poor coronary collateral circulation in stable coronary artery disease patients. A high neutrophil/lymphocyte ratio predicts inadequate collateral development.

Area of Science:

  • Cardiology
  • Hematology
  • Vascular Biology

Background:

  • Hematological parameters influence prognosis in cardiovascular diseases.
  • The association between hematological markers and coronary collateral (CC) circulation in stable coronary artery disease (CAD) remains unclear.

Purpose of the Study:

  • To examine the relationship between hematological parameters and CC vessel development in patients with stable CAD.
  • Investigate if mean platelet volume (MPV) and neutrophil/lymphocyte (N/L) ratio correlate with CC formation.

Main Methods:

  • Retrospective analysis of 96 stable CAD patients with occluded coronary arteries.
  • Coronary angiography used to assess CC development (Rentrop grades).
  • Multivariate logistic regression identified independent predictors of CC circulation.

Main Results:

  • Higher MPV and N/L ratios were observed in patients with poor CCs (Rentrop grades 0-1).
  • Significant negative correlations found between Rentrop score and both MPV and N/L ratio.
  • N/L ratio independently predicted poor CC development (OR 0.762, P=0.04).

Conclusions:

  • Neutrophil/lymphocyte ratio and MPV are associated with diminished coronary collateral circulation.
  • Elevated N/L ratio is a significant predictor of poor CC development in stable CAD.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
769
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
500
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
450
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
954